The spectrum of histopathological findings after SVR to DAA for recurrent HCV infection in liver transplant recipients-Reference-Cited by-同舟云学术

The spectrum of histopathological findings after SVR to DAA for recurrent HCV infection in liver transplant recipients

Published:2021-09-08 Issue: Volume: Page:
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Sanghi Vedha,Romero-Marrero Carlos,Flocco Gianina,Graham Rondell P.,Abduljawad Baraa,Niyazi Fadi,Asfari Mohammad M.,Hashimoto Koji,Eghtesad Bijan,Menon K. V. Narayanan,Aucejo Federico N.,Lopez Rocio,Yerian Lisa M.,Allende Daniela S.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00428-021-03191-6.pdf

Reference17 articles.

1. Kwong A, Kim WR, Lake JR et al (2020) OPTN/SRTR 2018 Annual data report: liver. Am J Transplant 20:193–299. https://doi.org/10.1111/ajt.15674

2. Gane EJ (2008) The natural history of recurrent hepatitis C and what influences this. Liver Transplant 14:S36–S44. https://doi.org/10.1002/lt.21646

3. Yilmaz N, Shiffman ML, Stravitz RT et al (2007) A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation. Liver Transplant 13:975–983. https://doi.org/10.1002/lt.21117

4. Thuluvath PJ, Krok KL, Segev DL, Yoo HY (2007) Trends in post–liver transplant survival in patients with hepatitis C between 1991 and 2001 in the united states. Liver Transplant 13:719–724. https://doi.org/10.1002/lt.21123

5. Picciotto FP, Tritto G, Lanza AG et al (2007) Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation. J Hepatol 46:459–465. https://doi.org/10.1016/j.jhep.2006.10.017